Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Globe & Mail Article
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Craigbadon Oct 05, 2016 1:41pm
35 Views
Post# 25312700

RE:RE:RE:Globe & Mail Article

RE:RE:RE:Globe & Mail ArticleThompsons lawsuit won't go well, he has committed multiple securities violations since the suit was filed. He'll end up paying Cohodes legal bills. Thompson will just further embarrass himself imo.

Investin wrote: LAXTICE, THE PRICE WILL RECOVER, AND COHODES WILL FOCUS MORE ON RAISING CHIKENS AND COWS TO PAY THOMPSON 4 ML.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities